Page last updated: 2024-12-10

10-deoxymethynolide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

10-Deoxymethynolide is a **macrolide antibiotic** produced by the bacterium *Streptomyces sp.* It is a **potent inhibitor of bacterial protein synthesis**, specifically targeting the **elongation factor G (EF-G)**.

Here's why 10-deoxymethynolide is important for research:

**1. Antibacterial Activity:**
* Its potent inhibition of EF-G makes it a promising candidate for the development of new antibiotics against **multidrug-resistant (MDR) bacteria**.
* It shows activity against a broad spectrum of bacteria, including **Gram-positive**, **Gram-negative**, and **anaerobic** strains.

**2. Unique Mechanism of Action:**
* 10-Deoxymethynolide binds to EF-G differently than other macrolides, suggesting a **novel mechanism of action**. This is important because it could help circumvent resistance mechanisms that target other macrolides.

**3. Structural Insights:**
* The molecule's unique structure allows for structural studies to better understand the **interaction between EF-G and antibiotics**. This information can be used to design more effective and specific antibiotics.

**4. Lead Compound for Drug Development:**
* 10-Deoxymethynolide serves as a **lead compound** for the development of new antibiotics. Researchers are exploring its potential for clinical use by modifying its structure to improve its pharmacological properties.

**5. Tool for Studying Bacterial Protein Synthesis:**
* It can be used as a **tool to study the mechanism of bacterial protein synthesis** and to identify potential targets for new antibiotics.

**Overall, 10-deoxymethynolide is a promising molecule with significant potential for the development of new antibiotics and the advancement of our understanding of bacterial protein synthesis.**

10-deoxymethynolide: structure given in first source; parent aglycone of methymycin and neomethymycin [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

10-deoxymethynolide : A macrolide that consists of oxacyclododec-9-ene-2,8-dione bearing four methyl substituents at positions 3, 5, 7 and 11 as well as a hydroxy group at position 4 and an ethyl substituent at position 12. The aglycone of the macrolide antibiotic 10-deoxymethymycin. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID5282031
CHEBI ID29461
SCHEMBL ID2880039
MeSH IDM0212720

Synonyms (10)

Synonym
(3r,4s,5s,7r,9e,11r,12r)-12-ethyl-4-hydroxy-3,5,7,11-tetramethyloxacyclododec-9-ene-2,8-dione
81644-19-1
10-deoxymethynolide
LMPK04000034
DB07703
(3r,4s,5s,7r,9e,11r,12r)-12-ethyl-4-hydroxy-3,5,7,11-tetramethyl-1-oxacyclododec-9-ene-2,8-dione
CHEBI:29461
SCHEMBL2880039
Q27096921
DTXSID801037179
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
metaboliteAny intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
macrolideA macrocyclic lactone with a ring of twelve or more members derived from a polyketide.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

PathwayProteinsCompounds
methymycin, neomethymycin and novamethymycin biosynthesis716

Research

Studies (10)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (10.00)18.2507
2000's8 (80.00)29.6817
2010's1 (10.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.07

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.07 (24.57)
Research Supply Index2.40 (2.92)
Research Growth Index4.46 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.07)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other10 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]